Grimes & Company’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $402K | Sell |
|
|||||
|
2025
Q2 | $370K | Buy |
|
|||||
|
2025
Q1 | $377K | Sell |
|
|||||
|
2024
Q4 | $353K | Buy |
|
|||||
|
2024
Q3 | $397K | Sell |
|
|||||
|
2024
Q2 | $402K | Sell |
|
|||||
|
2024
Q1 | $354K | Sell |
|
|||||
|
2023
Q4 | $383K | Sell |
|
|||||
|
2023
Q3 | $391K | Buy |
|
|||||
|
2023
Q2 | $410K | Sell |
|
|||||
|
2023
Q1 | $410K | Sell |
|
|||||
|
2022
Q4 | $479K | Buy |
|
|||||
|
2022
Q3 | $384K | Buy |
|
|||||
|
2022
Q2 | $330K | Buy |
|
|||||
|
2022
Q1 | $328K | Buy |
|
|||||
|
2021
Q4 | $285K | Sell |
|
|||||
|
2021
Q3 | $294K | Buy |
|
|||||
|
2021
Q2 | $290K | Sell |
|
|||||
|
2021
Q1 | $340K | Buy |
|
|||||
|
2020
Q4 | $291K | Buy |
|
|||||
|
2020
Q3 | $264K | Sell |
|
|||||
|
2020
Q2 | $255K | Sell |
|
|||||
|
2020
Q1 | $216K | Sell |
|
|||||
|
2019
Q4 | $291K | Sell |
|
|||||
|
2019
Q3 | $262K | Sell |
|
|||||
|
2019
Q2 | $276K | Sell |
|
|||||
|
2019
Q1 | $276K | Sell |
|
|||||
|
2018
Q4 | $274K | Sell |
|
|||||
|
2018
Q3 | $331K | Sell |
|
|||||
|
2018
Q2 | $307K | Sell |
|
|||||
|
2018
Q1 | $380K | Buy |
|
|||||
|
2017
Q4 | $307K | Hold |
|
|||||
|
2017
Q3 | $300K | Buy |
|
|||||
|
2017
Q2 | $296K | Sell |
|
|||||
|
2017
Q1 | $297K | Hold |
|
|||||
|
2016
Q4 | $260K | Sell |
|
|||||
|
2016
Q3 | $317K | Sell |
|
|||||
|
2016
Q2 | $296K | Sell |
|
|||||
|
2016
Q1 | $287K | Sell |
|
|||||
|
2015
Q4 | $404K | Buy |
|
|||||
|
2015
Q3 | $330K | Sell |
|
|||||
|
2015
Q2 | $377K | Sell |
|
|||||
|
2015
Q1 | $507K | Sell |
|
|||||
|
2014
Q4 | $630K | Sell |
|
|||||
|
2014
Q3 | $656K | Sell |
|
|||||
|
2014
Q2 | $817K | Sell |
|
|||||
|
2014
Q1 | $775K | Sell |
|
|||||
|
2013
Q4 | $6.72M | Buy |
|
|||||
|
2013
Q3 | $5.63M | Buy |
|
|||||
|
2013
Q2 | $4.77M | Buy |
|